(Q43972821)

28 November 2017

title

CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs (English)

1 reference

28 November 2017

main subject

angiogenesis inhibitor

1 reference

1 reference

Asa Svensson

1

1 reference

28 November 2017

Ulrika Bäckman

2

1 reference

28 November 2017

Elin Jonsson

3

1 reference

28 November 2017

Rolf Larsson

4

1 reference

28 November 2017

Rolf Christofferson

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

51

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

607-611

1 reference

https://scigraph.springernature.com/pub.10.1203/00006450-200205000-00011

28 November 2017

exact match

0 references

cites work

Neuroblastoma: current drug therapy recommendations as part of the total treatment approach

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Anti-angiogenic agents: clinical trial design and therapies in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Angiogenic factors as tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

Clinical applications of angiogenic growth factors and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200205000-00011

10.1203/00006450-200205000-00011

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

1019540076

0 references

1 reference